New York City, NY -- (SBWIRE) -- 12/26/2013 -- StockMarketIntel.com issues a special report on the following stocks: 22nd Century Group Inc (OTCBB:XXII), FEDERAL NATL PFD T (OTCBB:FNMAT), Chromadex Corp (OTCMKTS:CDXC), Advanced Cell Technology, Inc. (OTCMKTS:ACTC)
22nd Century Group Inc (OTCBB:XXII) gained 3.09%, trading on 378,209 shares, to end the trade at $2.00. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.46 and was moved to the maximum level of $2.05. The stock changed hands in a range of $1.92 to $2.05, bringing its market capitalization to about $99.44 million. 22nd Century Group, Inc., a plant biotechnology company, focuses on tobacco harm reduction and smoking cessation products produced from modifying the nicotine content in tobacco plants through genetic engineering and plant breeding.
For How Long XXII will fight for Profitability? Read This Trend Analysis report
FEDERAL NATL PFD T (OTCBB:FNMAT) added 0.10%, to complete the trading session at $9.96, with a total volume of 27,694 shares. The stock, on average, trades on a volume of 467,590 shares. In the past 52 weeks, the share price has not declined below $1.60 and above $10.50. It floated in a range of $9.90 to $9.99 during the last trading session, with a beta value of 1.31. Its market capitalization now moved to about $885.55 million.
For How Long FNMAT Gloss will Attract Investors? Find out via this report
Chromadex Corp (OTCMKTS:CDXC) recorded a gain of 2.74% and was in a range of $1.45-$1.56 before closing at $1.50. The share price hit its 52-week low of $0.50 and $1.56 was the best price. The stock completed the day with a total volume of 311,474 shares, versus an average volume of 304,652 shares. Chromadex Corporation is a provider of research and quality-control products and services to the natural products industry. The Company’s products are used by customers worldwide in the dietary supplement, food and beverage, cosmetic and pharmaceutical industries.
Will CDXC Continue To Move Higher? Find Out Here
Advanced Cell Technology, Inc. (OTCMKTS:ACTC) added 2.31%, bringing its market capitalization around $158.97 million. The total number of shares that changed hands during the session was 7.41 million shares, as compared to average trading volume of 4.10 million shares. The share price, after opening at $0.06, made a high of $0.06 and hovered above $0.06 to end the day at $0.0620. Advanced Cell Technology, Inc. is a biotechnology company focused on developing and commercializing human embryonic and adult stem cell technology in the emerging field of regenerative medicine. The Company has acquired, developed and maintained a portfolio of patents and patent applications that forms the base for its research and development efforts in the area of embryonic and adult stem cell research.
Why Should Investors Buy ACTC After The Recent Gain? Just Go Here and Find Out
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)